These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10651258)

  • 1. Gastric emptying in Type II (non-insulin-dependent) diabetes mellitus before and after therapy readjustment: no influence of actual blood glucose concentration.
    Holzäpfel A; Festa A; Stacher-Janotta G; Bergmann H; Shnawa N; Brannath W; Schernthaner G; Stacher G
    Diabetologia; 1999 Dec; 42(12):1410-2. PubMed ID: 10651258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C; Ramachandran A; Mohan V; Timothy H; Viswanathan M
    Horm Metab Res; 1986 Jun; 18(6):391-4. PubMed ID: 3525362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.
    Rachman J; Barrow BA; Levy JC; Turner RC
    Diabetologia; 1997 Feb; 40(2):205-11. PubMed ID: 9049482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
    Linnebjerg H; Park S; Kothare PA; Trautmann ME; Mace K; Fineman M; Wilding I; Nauck M; Horowitz M
    Regul Pept; 2008 Nov; 151(1-3):123-9. PubMed ID: 18675854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes mellitus in the elderly].
    van der Veen EA
    Tijdschr Gerontol Geriatr; 1990 Feb; 21(1):7-10. PubMed ID: 2180142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
    Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assisting effects of lithium on hypoglycemic treatment in patients with diabetes.
    Hu M; Wu H; Chao C
    Biol Trace Elem Res; 1997; 60(1-2):131-7. PubMed ID: 9404682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
    Rosak C; Hofmann U; Paulwitz O
    Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.
    Inzucchi SE; Maggs DG; Spollett GR; Page SL; Rife FS; Walton V; Shulman GI
    N Engl J Med; 1998 Mar; 338(13):867-72. PubMed ID: 9516221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euglycaemic hyperinsulinaemia does not affect gastric emptying in type I and type II diabetes mellitus.
    Kong MF; King P; Macdonald IA; Blackshaw PE; Horowitz M; Perkins AC; Armstrong E; Buchanan KD; Tattersall RB
    Diabetologia; 1999 Mar; 42(3):365-72. PubMed ID: 10096791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Horowitz M; Harding PE; Maddox AF; Wishart JM; Akkermans LM; Chatterton BE; Shearman DJ
    Diabetologia; 1989 Mar; 32(3):151-9. PubMed ID: 2753246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rehabilitation management on gastric emptying function in older adults with diabetes.
    Shao ZM; Yao JF; Chen J; Yu ZW; Yu XF; Zheng JJ; Tang X
    Genet Mol Res; 2014 Jan; 13(4):9244-52. PubMed ID: 24615075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin improves glycaemic control in patients with Type II diabetes mellitus.
    Ueno N; Inui A; Asakawa A; Takao F; Tani S; Komatsu Y; Itoh Z; Kasuga M
    Diabetologia; 2000 Apr; 43(4):411-5. PubMed ID: 10819233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating clinical trial data into new patterns of practice.
    Peragallo-Dittko V
    Diabetes Educ; 2009; 35 Suppl 1():18S-21S. PubMed ID: 19218563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.